Mesoblast (MESO) Total Non-Current Liabilities: 2015-2025
Historic Total Non-Current Liabilities for Mesoblast (MESO) over the last 8 years, with Jun 2025 value amounting to $84.6 million.
- Mesoblast's Total Non-Current Liabilities fell 26.78% to $84.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $84.6 million, marking a year-over-year decrease of 26.78%. This contributed to the annual value of $84.6 million for FY2025, which is 26.78% down from last year.
- According to the latest figures from Q2 2025, Mesoblast's Total Non-Current Liabilities is $84.6 million, which was down 29.08% from $119.3 million recorded in Q4 2024.
- Mesoblast's 5-year Total Non-Current Liabilities high stood at $130.2 million for Q4 2023, and its period low was $66.6 million during Q1 2021.
- Over the past 3 years, Mesoblast's median Total Non-Current Liabilities value was $117.4 million (recorded in 2024), while the average stood at $114.9 million.
- As far as peak fluctuations go, Mesoblast's Total Non-Current Liabilities tumbled by 34.20% in 2021, and later skyrocketed by 68.61% in 2022.
- Over the past 5 years, Mesoblast's Total Non-Current Liabilities (Quarterly) stood at $111.0 million in 2021, then grew by 2.26% to $113.5 million in 2022, then rose by 14.72% to $130.2 million in 2023, then declined by 8.36% to $119.3 million in 2024, then declined by 26.78% to $84.6 million in 2025.
- Its Total Non-Current Liabilities was $84.6 million in Q2 2025, compared to $119.3 million in Q4 2024 and $115.6 million in Q2 2024.